Medidata tips wearables data to enter regulatory filings by 2020

Glen De Vries

Medidata ($MDSO) president Glen de Vries has predicted drug developers will begin presenting digital biomarkers as evidence to regulators and payers within five years, Outsourcing-Pharma reports. De Vries highlighted the six-minute walk test--which is used in Duchenne muscular dystrophy trials--as one endpoint that could be improved by using wearables to gather digital biomarkers. Article